Caption Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
JT
PA
NAMI
Caption Management's TVTX Position: Q2 2026 in Review
Caption Management sold out of Travere Therapeutics (TVTX) in Q2 2026, closing a stake of 25,000 shares — an estimated $1.11M sold.
Caption Management first reported a position in TVTX in Q3 2022 and held it in 5 quarters. The position peaked at $1.44M in Q3 2025. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.
- Caption Management reported no remaining Travere Therapeutics position as of Q2 2026 after selling out during the quarter.
- Caption Management sold 25,000 Travere Therapeutics shares in Q2 2026, an estimated $1.11M.
- Caption Management first reported a position in Travere Therapeutics in Q3 2022 and held it in 5 quarters.
- Caption Management's Travere Therapeutics position peaked at $1.44M in Q3 2025.
- 320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.
Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.